查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881705

口腔癌快速檢測試劑盒市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、最終用戶、地區和競爭格局分類，2020-2030年預測

Oral Cancer Rapid Test Kit Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End user, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球口腔癌快速檢測試劑盒市場規模為10.1259億美元，預計2030年將以4.3%的複合年成長率成長至13.0359億美元。口腔癌快速檢測試劑盒是一種非侵入性診斷工具，旨在快速識別潛在的口腔癌病例，主要用於即時檢測，以促進早期發現。市場擴張的根本促進因素是全球口腔癌發生率的不斷上升以及人們對早期診斷和定期篩檢益處的認知不斷提高。

市場概覽
預測期 2026-2030
2024年市場規模 10.1259億美元
2030年市場規模 13.0359億美元
2025-2030年複合年成長率 4.3%
成長最快的細分市場 晶片實驗室
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球口腔癌快速檢測試劑盒市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依類型（Onc Alert 口腔癌實驗室檢測、晶片實驗室檢測、Insilixa 檢測、Prevo-Check 檢測）
    • 按最終使用者（醫院和診所、門診中心、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美口腔癌快速檢測試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲口腔癌快速檢測試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區口腔癌快速檢測試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲口腔癌快速檢測試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲口腔癌快速檢測試劑盒市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球口腔癌快速檢測試劑盒市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Abbott Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • GRAIL, LLC
  • Henry Schein, Inc.
  • Quest Diagnostics Inc.
  • Quidel Corp.
  • Siemens Healthineers AG
  • Trinity Biotech plc
  • Viome Life Sciences, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 21727

The Global Oral Cancer Rapid Test Kit Market, valued at USD 1012.59 Million in 2024, is projected to experience a CAGR of 4.3% to reach USD 1303.59 Million by 2030. Oral Cancer Rapid Test Kits are non-invasive diagnostic tools designed for the swift identification of potential oral cancer cases, primarily employed in point-of-care settings to facilitate early detection. The market's expansion is fundamentally driven by the escalating global incidence of oral cancer and increasing awareness regarding the benefits of early diagnosis and regular screening programs.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1012.59 Million
Market Size 2030USD 1303.59 Million
CAGR 2025-20304.3%
Fastest Growing SegmentLab on Chip
Largest MarketNorth America

Key Market Drivers

The escalating global incidence of oral cancer fundamentally drives the Oral Cancer Rapid Test Kit Market, necessitating accessible and efficient diagnostic tools. Early detection is critical for improving patient outcomes, as oral cancer often presents in advanced stages with poorer prognoses. For example, according to Cancer Research UK, in 2022, there were 389,846 new cases of mouth and oral cancer globally. This substantial annual caseload underscores the urgent need for widespread early screening. Rapid test kits are ideally positioned to meet this demand, enabling timely identification in diverse healthcare settings and facilitating prompt intervention. The rising global prevalence of oral cancer sustains the imperative for proactive screening measures that these rapid diagnostic solutions can effectively support.

Key Market Challenges

The limited public and professional awareness regarding oral cancer risk factors, the importance of early detection, and the availability of rapid testing options significantly impedes the growth of the Global Oral Cancer Rapid Test Kit Market. This challenge directly restricts the adoption and utilization of these diagnostic tools. When both the general public and healthcare professionals lack comprehensive education on oral cancer's subtle initial signs and the critical benefits of early screening, the demand for rapid test kits remains subdued.

Key Market Trends

The expansion of at-home testing solutions represents a pivotal trend, broadening access to oral cancer screening beyond traditional clinical settings. This trend addresses the demand for convenient diagnostic tools, empowering individuals to undertake preliminary screening privately and efficiently. For example, the U. S. Centers for Disease Control and Prevention reported that cancer screening rates declined by 15-2% since 2020, highlighting the substantial need for accessible home-based alternatives.

Key Market Players

  • Abbott Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • GRAIL, LLC
  • Henry Schein, Inc.
  • Quest Diagnostics Inc.
  • Quidel Corp.
  • Siemens Healthineers AG
  • Trinity Biotech plc
  • Viome Life Sciences, Inc.

Report Scope:

In this report, the Global Oral Cancer Rapid Test Kit Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oral Cancer Rapid Test Kit Market, By Type:

  • Onc Alert Oral Cancer LAB
  • Lab on Chip
  • Insilixa Test
  • Prevo- Check

Oral Cancer Rapid Test Kit Market, By End user:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Oral Cancer Rapid Test Kit Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Oral Cancer Rapid Test Kit Market.

Available Customizations:

Global Oral Cancer Rapid Test Kit Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Cancer Rapid Test Kit Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Onc Alert Oral Cancer LAB, Lab on Chip, Insilixa Test, Prevo- Check)
    • 5.2.2. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Oral Cancer Rapid Test Kit Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End user
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oral Cancer Rapid Test Kit Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End user
    • 6.3.2. Canada Oral Cancer Rapid Test Kit Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End user
    • 6.3.3. Mexico Oral Cancer Rapid Test Kit Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End user

7. Europe Oral Cancer Rapid Test Kit Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End user
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Oral Cancer Rapid Test Kit Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End user
    • 7.3.2. France Oral Cancer Rapid Test Kit Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End user
    • 7.3.3. United Kingdom Oral Cancer Rapid Test Kit Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End user
    • 7.3.4. Italy Oral Cancer Rapid Test Kit Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End user
    • 7.3.5. Spain Oral Cancer Rapid Test Kit Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End user

8. Asia Pacific Oral Cancer Rapid Test Kit Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End user
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Oral Cancer Rapid Test Kit Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End user
    • 8.3.2. India Oral Cancer Rapid Test Kit Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End user
    • 8.3.3. Japan Oral Cancer Rapid Test Kit Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End user
    • 8.3.4. South Korea Oral Cancer Rapid Test Kit Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End user
    • 8.3.5. Australia Oral Cancer Rapid Test Kit Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End user

9. Middle East & Africa Oral Cancer Rapid Test Kit Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End user
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Oral Cancer Rapid Test Kit Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End user
    • 9.3.2. UAE Oral Cancer Rapid Test Kit Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End user
    • 9.3.3. South Africa Oral Cancer Rapid Test Kit Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End user

10. South America Oral Cancer Rapid Test Kit Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End user
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Oral Cancer Rapid Test Kit Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End user
    • 10.3.2. Colombia Oral Cancer Rapid Test Kit Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End user
    • 10.3.3. Argentina Oral Cancer Rapid Test Kit Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Oral Cancer Rapid Test Kit Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. F. Hoffmann-La Roche AG
  • 15.4. Beckman Coulter, Inc.
  • 15.5. Becton, Dickinson and Co.
  • 15.6. Bio-Rad Laboratories, Inc.
  • 15.7. Danaher Corp.
  • 15.8. GRAIL, LLC
  • 15.9. Henry Schein, Inc.
  • 15.10. Quest Diagnostics Inc.
  • 15.11. Quidel Corp.
  • 15.12. Siemens Healthineers AG
  • 15.13. Trinity Biotech plc
  • 15.14. Viome Life Sciences, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer